Placebo IV Infusion
Sponsors
Cytokinetics, Pfizer, GlaxoSmithKline, pharmaand GmbH, Civi Biopharma, Inc.
Conditions
Angina PectorisBioavailabilityComplete ResponseDementia FrontotemporalEpithelial Ovarian CancerFIGO Stage III-IVFallopian Tube CancerHealthy
Phase 1
Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People
TerminatedNCT01162889
Start: 2010-06-30End: 2012-01-31Updated: 2012-03-15
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771
CompletedNCT05640531
Start: 2011-12-01End: 2012-06-27Updated: 2022-12-07
Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy
RecruitingNCT06138743
Start: 2024-03-04End: 2026-12-31Target: 78Updated: 2026-08-11
Phase 1 Study Involving SAB01 and Healthy Participants
RecruitingNCT07815561
Start: 2026-08-31End: 2027-05-01Target: 88Updated: 2026-09-11
Phase 2
PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina
CompletedNCT00682565
Start: 2008-04-30End: 2009-03-31Updated: 2018-08-21
Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)
CompletedNCT03867097
Start: 2019-03-07End: 2019-08-06Updated: 2025-05-25
Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia
Not yet recruitingNCT07154485
Start: 2025-10-01End: 2028-08-01Target: 15Updated: 2025-09-04
Phase 3
A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
TerminatedNCT02377466
Start: 2016-02-29End: 2017-07-24Updated: 2020-07-28
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Active, not recruitingNCT03522246
Start: 2018-05-14End: 2030-12-30Updated: 2025-06-24
Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)
CompletedNCT04040322
Start: 2019-10-14End: 2021-06-09Updated: 2025-05-25